Skip to main content
OpenTrials
Completed

NCT Number: NCT00605436

Yoga for the Treatment of Metabolic Syndrome

We tested the following hypotheses:

1. That a standardized yoga therapy will improve insulin sensitivity (primary outcome), and other features of the metabolic syndrome such as hypertension and dyslipidemia (secondary outcomes), we will perform a 2-hour oral glucose tolerance test, fasting blood tests, and a physical examination before and after randomization of subjects to a 10-week yoga therapy intervention or wait-list control group. 2. That a yoga therapy is feasible in overweight and underactive individuals with the metabolic syndrome, that adherence to a yoga intervention is acceptable, and that yoga therapy is associated with improved quality of life, we will assess the adherence to twice-weekly yoga group sessions (for weeks1-5) and weekly yoga group sessions (for weeks 6-10), frequency of home yoga therapy practice, and self-reported quality of life before and after the intervention in both treatment groups. 3. To elucidate a potential mechanism for the effect of yoga on changes in insulin resistance by evaluating markers of inflammation from adipose tissue (adipocytokines). We hypothesize that these biochemical parameters will show modest improvement with yoga therapy and that changes in these parameters will be associated with improvements in insulin sensitivity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

University of California, San Francisco

San Francisco, California, 94115, United States

About this study

Study Interventions: There will be a 12-week intervention period.

  • Yoga Therapy Group: Those randomized to yoga therapy will receive twice-weekly group yoga sessions at the Osher Center for the entire intervention period. The yoga postures and breathing techniques will be taught by a qualified and certified yoga instructor using a standardized protocol that was determined by a Yoga Expert Panel. Each group yoga session will take approximately 90 minutes. Participants will also be required to practice yoga at home at least 3 times per week, and be given yoga materials (mat, blocks, straps), an instruction manual, and a video for their use at home. They will be asked to keep a calendar log of the dates/times that they practiced yoga at home. This group will also receive a 20-30 minute session with a counselor to discuss Standard Health Education at the beginning of the 12-week intervention. This session will be similar to the control group intervention.
  • Standard Health Education Group: Participants assigned to the standard health education group will receive an individual 20-30 minute session with a trained research associate within a week of their baseline visit. In this session, participants will be informed of the importance of a healthy lifestyle, given written information of the Food Guide Pyramid12 and told to follow the equivalent of the National Cholesterol Education Program Step I diet13. They will be counseled to reduce weight and increase physical activity. This is similar to the intervention given to the "Standard Lifestyle Group" in the Diabetes Prevention Program4.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • to be between the ages of 30 and 65 years,
  • fulfill at least three criteria for the metabolic syndrome per the NCEP guidelines:
  • waist circumference (>88 cm for women; >102 cm for men),
  • HDL-cholesterol (<50 mg/dl for women; <40 mg/dl for men),
  • triglycerides >=150 mg/dL
  • fasting glucose >=100 mg/dL, and/or
  • high blood pressure (>=130/>=85 or use of antihypertensive medication), and
  • report an underactive or sedentary lifestyle defined as accumulating less than 30 minutes of moderate intensity endurance exercise 5 days per week.

Exclusion criteria

  • Pregnancy or lactation
  • Coronary heart disease (defined as a myocardial infarction or cardiac intervention with percutaneous transluminal catheterization or coronary artery bypass graft surgery) event or hospitalization in the past 6 months
  • Chronic illnesses: cancer, kidney disease, cirrhosis, rheumatogic diseases, or chronic infections
  • Current use of these medications: oral diabetes medications, insulin, steroid hormones, oral contraceptives, hormone replacement therapy, niacin, fibrates.
  • Regular participation (>1/week) yoga for past 3 months or concurrent use of yoga
  • Current major psychiatric illness, cognitive impairment, or substance abuse
  • Plans to move out of the study region within 6 months
  • Life-expectancy of < 6 months
  • Concurrent enrollment in any other studies, experimental therapies, or blinded treatments

Treatment and study plan

Restorative yoga therapy

Behavioral

3-hour workshop at study initiation. Then twice-weekly group yoga classes for 5 weeks, then once-weekly group yoga classes for 5 weeks. Home yoga practice for 90 minutes/week throughout the 10 week trial.

Primary outcomes

  1. Fasting plasma glucose level

    Time frame: 10 weeks

Secondary outcomes

  1. Feasability of yoga postures

    Time frame: 10 weeks

  2. Adherence to protocol

    Time frame: 10 weeks

  3. Blood pressure

    Time frame: 10 weeks

  4. Insulin sensitivity

    Time frame: 10 weeks

  5. Weight

    Time frame: 10 weeks

  6. Waist circumference

    Time frame: 10 weeks

  7. Heart rate variability

    Time frame: 10 weeks

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Cliff Lede Foundation

Registry information

Official study title

Restorative Yoga for Therapy of the Metabolic Syndrome: A Pilot Trial

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Jan 31, 2008
Registry last updated
Jan 31, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.